As Apple starts selling Apple Watch Series 9 and Ultra 2 models without the blood oxygen sensor enabled, Masimo CEO Joe Kiani confirmed to Bloomberg that there has been no chat with Apple about a ...
For the second time in the last year, the U.S. International Trade Commission (ITC) has determined that Apple violated a competitor’s patents in a health-tracking feature of its popular smartwatch, ...
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that Radius VSM™, a patient-worn, continuous multi-parameter vital signs monitor, has received FDA 510(k) clearance. Designed on ...
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that the Masimo W1™ medical watch has received FDA 510(k) clearance for over-the-counter (OTC) and prescription use (Rx). Masimo ...
(RTTNews) - Masimo (MASI) said that the U.S. FDA has cleared SedLine brain function monitoring for pediatric patients (1-17 years of age) and the SedLine Pediatric EEG Sensor. With this clearance, the ...
An International Trade Commission judge ruled that Apple infringed on one of five Masimo patents related to using light sensors to measure the amount of oxygen in the blood. After months of waiting ...
Philips and Masimo have renewed a longstanding strategic partnership to develop patient care solutions. This time, the companies stated that their collaboration would primarily focus on advancing ...
A federal jury in California has ruled that Apple Inc. (NASDAQ: AAPL) must pay Masimo Corporation (NASDAQ: MASI) $634 million for infringing a patent related to blood-oxygen reading technology. The ...
Masimo Corp. in Irvine received FDA clearance for the sale of its TFA-1 Single-Patient-Use Adhesive Forehead Sensor. The forehead sensor measures oxygen saturation, similar to the company’s current ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback